Stocksigma LogoStocksigma Logo

Kimia Biosciences Schedules Board Meeting to Approve Q2 and H1 FY27 Results

Kimia Biosciences Limited has scheduled a Board of Directors meeting for 13th Nov'26 to consider and approve the standalone un-audited financial results

Kimia Biosciences Schedules Board Meeting to Approve Q2 and H1 FY27 Results

Kimia Biosciences Ltd 路 Intimation 路 13 Nov 2026, 5:30 am

Kimia Biosciences Schedules Board Meeting to Approve Q2 and H1 FY27 Results Kimia Biosciences Limited has scheduled a Board of Directors meeting for 13th Nov'26 to consider and approve the standalone un-audited financial results for the second quarter and half year ended 30th Sep'26. In compliance with SEBI insider trading regulations, the trading window for dealing in company equity shares by designated persons and their immediate relatives has been closed effective 1st Oct'26 and will remain closed until 48 hours post-declaration of the financial results.

Original exchange filing (PDF)

More announcements from Kimia Biosciences Ltd

All Kimia Biosciences Ltd announcements